Global Molecular Diagnostics Market was valued at US$ 6,242.6 million in 2018 and is anticipated to reach US$ 9,546.2 million by 2025 displaying a reasonable CAGR of 6.3% over the forecast period (2019-2025). Molecular Diagnostics is the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and monitoring response to therapy. The market of Molecular Diagnostics market is anticipated to grow enormously owing to factors such as rising geriatric population, increasing prevalence of chronic diseases, increasing adoption of Point-of-care diagnosis, advances in genomics and proteomics, and introduction of technologically advanced products. The growing incidence of infectious diseases and cancer is increasing the demand for molecular diagnostics techniques. The rapid advancements witnessed in the molecular biology technologies, development of molecular diagnostic technologies to automated processes, growing awareness about molecular diagnostics usage for the detection of different diseases in developing countries is boosting the overall market growth. The investment in unifying technology, consolidation and automation of labs, and shift to data-driven healthcare will mark as a trend in this industry. However, high prices of molecular diagnostics tests and unfavourable reimbursement policies will act as the major challenges in the growth of this market. Points of Entry in the Diagnostics Supply Chain In this evolving environment, it is a business imperative for diagnostic manufacturers to understand, demonstrate, and clearly articulate how their offerings can lead not only to better patient outcomes but also create value for a variety of key stakeholders. There are many ways that diagnostic technologies can impact the quality and cost of care. Medical diagnostic tests and technologies are at the forefront of health care and personalized medicine. These technologies increasingly are a key component in ensuring that the right treatment gets to the right patient at the right time. Advances in life sciences and in test technologies are making diagnostics ever more central in the delivery of effective health care. It is well understood by health care stakeholders that diagnostics significantly affect clinical decision-making. Nevertheless, it is critical for diagnostic test developers to be able to demonstrate the value of their tests to a variety of stakeholders in the face of growing scrutiny and cost pressure directed at almost every health care sector “Reagents are the majorly used product under the Molecular Diagnostics market, holding ~69% share in 2018” Based on product type the global molecular diagnostics market is bifurcated into Instruments, Reagents and services and others. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to the high demand for over-the-counter diagnostic tests, rise in adoption of these tests in nonmedical facilities, such as home. “Polymerase chain reaction (PCR) is expected to dominate the technique segment during the analyzed period.” Molecular diagnostics market, based on technique is segmented into Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and others. The PCR segment occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025 owing to the increased usage and advancements in PCR techniques. Molecular Diagnostics Market Size by Technique Type, Global, 2018-2025 (US$ Million) “Molecular Diagnostic techniques are majorly applied for Virology study, the segment generated revenue of US$ 2,243.9 million in 2018” The molecular diagnostics market is applied in various medical fields including Microbiology, Virology, Hospital Acquired Infections (HAI), Genetic Testing, Oncology, Pharmacogenetics, Human Leukocytes Antigen (HLA), Blood Screening and others. In 2018, Virology segment dominated the market and is anticipated to dominate this segment in 2025. However, Oncology application segment is expected to witness highest CAGR growth of 8.27% during the forecast period 2019-2025. “Amongst end-users’ type, hospitals are anticipated to dominate Global Molecular Diagnostics market by 2025.” Hospitals, clinics & labs and others are the major end-users of the molecular diagnostic technology. In 2018, the application of the technology was dominated by Hospitals segment. The increased adoption in hospitals is driven by high procedure volume and extensive presence of ancillary support in terms of manpower and infrastructure. However, Clinics & labs application type is expected to witness reasonable CAGR growth during the analyzed period. “North America dominated the market for molecular diagnostic technology in 2018, followed by Asia-Pacific and Europe” For a deep-dive analysis of the industry, detailed regional/country-level analysis is conducted for markets including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World). In 2018, North America generated revenue of US$ 2,964.9 million, however, Asia-Pacific is expected to witness highest CAGR of 6.74% during the forecast period. The dominance of North America is majorly driven by the presence of a well-established diagnostic infrastructure, technological advancements, patient awareness and presence of advanced products in the field of molecular diagnostics. Competitive Landscape-Top 10 Market Players Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Hologic, Inc., Qiagen, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the Global Molecular Diagnostics market industry. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products. Reasons to buy: Current and future market size from 2018 to 2025 in terms of value (US$)

Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry

Country-level details of the overall adoption of molecular diagnostics market

A quick review of overall industry performance at a glance

In-depth analysis of key industry players

A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry

Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups

The study comprehensively covers the market across different segments and sub-segments of the technology

Regions/countries Covered: North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World) Customization Options: UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Molecular Diagnostics Market can be customized to the country level or any other market segment.

1.1 Market Definition 1.2 Objective of the Study 1.3 Limitation 1.4 Stakeholders 1.5 Currency used in the Report 1.6 Scope of the Global Molecular Diagnostics Market Study 2 RESEARCH METHODOLOGY 2.1 Research Methodology for Global Molecular Diagnostics (MDx) Market Study 2.1.1 Main objective of the Global Molecular Diagnostics Market Study 3 COMPREHENSIVE ASSESSMENT OF THE VALUE OF DIAGNOSTIC TESTS 3.1 General Overview 3.2 Capturing the full spectrum of the value that a diagnostic test contributes 3.3 Ensuring that robust analyses underpin the value assessment 3.4 Accounting for variation in diagnostic test types in value assessment methods 3.5 Aligning on how to define and measure value drivers 3.5.1 Value Driver: Clinical Impact 3.5.2 Value Driver: Non-Clinical Patient Impact 3.5.3 Value Driver: Care Delivery Revenue and Cost Impact 3.5.4 Value Driver: Public/Population Impact 4 REFRAMING THE DIAGNOSTICS INDUSTRY 4.1 General Overview 5 EXECUTIVE SUMMARY 6 INDUSTRY PERFORMANCE 7 RISK MITIGATION 7.1 General Overview 7.2 Supply Chain 7.3 Risk Assessment 7.4 Bulk, Custom and Contract Manufacturing 5 MARKET OVERVIEW 5.1 Introduction of Molecular Diagnostics Market 5.1.1 Essential Components or Attributes of Diagnostics 5.1.2 Main Categories of Diagnostics 5.1.3 Settings of Use 5.2 Current and Future Use of Diagnostic Products 5.2.1 Primary Uses of Diagnostics 5.2.1.1 Predictive Applications/Screening/Early Disease Detection 5.2.1.2 Diagnostic 5.2.1.3 Secondary Risk Assessment – Prognostic 5.2.1.4 Drug Selection/Treatment Targeting 5.2.1.5 Disease/Condition Monitoring and Management 5.2.2 Molecular Diagnostics: Overview of Future Trends and Directions 5.2.2.1 Predict Disease Before Symptoms Appear 5.2.2.2 Predict Beneficial and Adverse Treatment Effects 5.2.2.3 Enable Personalized “Real-Time” Treatment and Disease Management Regimens 5.2.2.4 Facilitate Point-of-care and Near-patient Testing 5.2.2.5 Enable Home Testing 5.2.2.6 Public Health, Environmental, Bioterrorism Applications 5.2.2.7 Technology and Testing System Integration 5.2.3 The Importance of Molecular Diagnostics 5.2.4 Market Drivers 5.2.4.1 Increasing Prevalence of Chronic Diseases 5.2.4.2 Rising Geriatric Population 5.2.4.3 Increasing adoption of Point-of-Care Diagnosis 5.2.4.4 Technology Advancement in the In-Vitro Diagnostics 5.2.4.5 Advances in Genomics and Proteomics 5.2.5 Market Restraints 5.2.5.1 Unfavorable Reimbursement Policies for In-Vitro Diagnostics 5.2.5.2 High Prices of Molecular Diagnostics Tests 5.2.6 Market Opportunities 5.2.6.1 Increasing Support from Governments and Key Players 5.2.6.2 Growing Significance of Companion Diagnostics 5.2.7 Market Trends 5.2.7.1 Changing Reimbursement Models and Regulations 5.2.7.2 Investing in Unifying Technology 5.2.7.3 Consolidation and Automation of Labs 5.2.7.4 Shift to Data-Driven Healthcare 5.2.7.5 Consumer Lab Testing 5.2.7.6 Healthcare Convergence 6 REGULATIONS AND REIMBURSEMENT POLICY 6.1 Regulation 6.1.1 United States 6.1.1.1 Approval/Clearance of Molecular Diagnostic Instruments 6.1.1.2 Recommendations for Submissions for Molecular Diagnostic Instruments with Combined Functions 6.1.1.2.1 New Instruments 6.1.1.2.2 Existing Approved/Cleared Instruments 6.1.1.2.3 Submission Information, Labeling, and Marketing 6.1.1.2.4 Promotion and Labeling Issues 6.1.1.2.5 Software/Hardware Changes 6.1.1.2.6 Third-Party Assay Developers 6.1.1.2.7 MDR Reporting 6.2 Reimbursement 7 KEY MARKET INDICATORS 7.1 Demand Side Analysis 7.1.1 Some of the Key Facts about Aging Population 7.1.2 Health Conditions Associated with Aging 7.1.2.1 Some of the key facts about Cardiovascular Diseases (CVD) as per WHO 7.2 Supply Side Analysis 7.2.1 Product Launches 7.2.2 Partnership 7.2.3 Business Expansions and Investments 7.2.4 Merger and Acquisition 7.3 SWOT Analysis of Molecular Diagnostics 7.4 Value Chain Analysis of Molecular Diagnostics 8 MARKET INSIGHT BY PRODUCT 8.1 General Overview 8.1.1 Reagents 8.1.2 Instruments Services 9 MARKET INSIGHT BY TECHNIQUE 9.1 General Overview 9.1.1 Polymerase chain reaction (PCR) 9.1.2 Transcription-Mediated Amplification (TMA) 9.1.3 In Situ Hybridization & FISH 9.1.4 DNA Sequencing & Next-Generation Sequencing (NGS) 9.1.5 Case Study: Next Generation Sequencing for Clinical Diagnostics 9.1.6 Chips and Microarrays 9.1.7 Others 10 MARKET INSIGHT BY APPLICATION 10.1 General Overview 10.1.1 Microbiology 10.1.2 Virology 10.1.3 Hospital Acquired Infections (HAI) 10.1.4 Genetic Testing 10.1.5 Oncology 10.1.6 Pharmacogenetics 10.1.7 Human Leukocyte Antigen (HLA Testing) 10.1.8 Blood Screening 10.1.9 Others 11 MARKET INSIGHT BY END USER 11.1 General Overview 11.1.1 Hospitals 11.1.2 Clinics & Laboratory 11.1.3 Others 12 MARKET INSIGHT BY REGION 12.1 General Overview 12.2 North America MDx Market Insight 12.2.1 North America Molecular Diagnostics Market by Product 12.2.2 North America Molecular Diagnostics Market by Technique 12.2.3 North America Molecular Diagnostics Market by Application 12.2.4 North America Molecular Diagnostics Market by End Users 12.2.5 North America Molecular Diagnostics Market by Country 12.2.5.1 United States 12.2.5.1.1 Key Findings on Healthcare Spending in the US, 2017 12.2.5.1.2 US Health Spending by Type of Service or Product, 2017 12.2.5.1.3 Health Spending by Major Sources of Funds 12.2.5.1.4 United States Molecular Diagnostics Market by Product 12.2.5.1.5 United States Molecular Diagnostics Market by Technique 12.2.5.1.6 United States Molecular Diagnostics Market by Application 12.2.5.1.7 United States Molecular Diagnostics Market by End Users 12.2.5.2 Canada 12.2.5.2.1 Key Findings on Canada Healthcare Spending, 2018 12.2.5.2.2 Key Findings on Hospital sector Spending in Canada, 2017 12.2.5.2.3 Canada Molecular Diagnostics Market by Product 12.2.5.2.4 Canada Molecular Diagnostics Market by Technique 12.2.5.2.5 Canada Molecular Diagnostics Market by Application 12.2.5.2.6 Canada Molecular Diagnostics Market by End Users 12.2.5.5 Rest of North America 12.2.5.5.1 Rest of NA Molecular Diagnostics Market by Product 12.2.5.5.2 Rest of NA Molecular Diagnostics Market by Technique 12.2.5.5.3 Rest of NA Molecular Diagnostics Market by Application 12.2.5.5.4 Rest of NA Molecular Diagnostics Market by End Users 12.3 Europe Molecular Diagnostic Market Insight 12.3.1 Europe Molecular Diagnostics Market by Product 12.3.2 Europe Molecular Diagnostics Market by Technique 12.3.3 Europe Molecular Diagnostics Market by Application 12.3.4 Europe Molecular Diagnostics Market by End Users 12.3.5 Europe Molecular Diagnostics Market by Country 12.3.5.1 Germany 12.3.5.1.1 Germany Molecular Diagnostics Market by Product 12.3.5.1.2 Germany Molecular Diagnostics Market by Technique 12.3.5.1.3 Germany Molecular Diagnostics Market by Application 12.3.5.1.4 Germany Molecular Diagnostics Market by End Users 12.3.5.2 France 12.3.5.2.1 France Molecular Diagnostics Market by Product 12.3.5.2.2 France Molecular Diagnostics Market by Technique 12.3.5.2.3 France Molecular Diagnostics Market by Application 12.3.5.2.4 France Molecular Diagnostics Market by End Users 12.3.5.3 Spain 12.3.5.3.1 Spain Molecular Diagnostics Market by Product 12.3.5.3.2 Spain Molecular Diagnostics Market by Technique 12.3.5.3.3 Spain Molecular Diagnostics Market by Application 12.3.5.3.4 Spain Molecular Diagnostics Market by End Users 12.3.5.4 Italy 12.3.5.4.1 Italy Molecular Diagnostics Market by Product 12.3.5.4.2 Italy Molecular Diagnostics Market by Technique 12.3.5.4.3 Italy Molecular Diagnostics Market by Application 12.3.5.4.4 Italy Molecular Diagnostics Market by End Users 12.3.5.5 United Kingdom 12.3.5.5.1 United Kingdom Molecular Diagnostics Market by Product 12.3.5.5.2 United Kingdom Molecular Diagnostics Market by Technique 12.3.5.5.3 United Kingdom Molecular Diagnostics Market by Application 12.3.5.5.4 United Kingdom Molecular Diagnostics Market by End Users 12.3.5.6 Rest of Europe 12.3.5.6.1 Rest of Europe Molecular Diagnostics Market by Product 12.3.5.6.2 Rest of Europe Molecular Diagnostics Market by Technique 12.3.5.6.3 Rest of Europe Molecular Diagnostics Market by Application 12.3.5.6.4 Rest of Europe Molecular Diagnostics Market by End Users 12.4 Asia-Pacific Molecular Diagnostics Market Insight 12.4.1 Asia-Pacific Molecular Diagnostics Market by Product 12.4.2 Asia-Pacific Molecular Diagnostics Market by Technique 12.4.3 Asia-Pacific Molecular Diagnostics Market by Application 12.4.4 Asia-Pacific Molecular Diagnostics Market by End Users 12.4.5 Asia-Pacific Molecular Diagnostics Market by Country 12.4.5.1 China 12.4.5.1.1 China In-Vitro Diagnostics Services Market 12.4.5.1.2 China Molecular Diagnostics Market by Product 12.4.5.1.3 China Molecular Diagnostics Market by Technique 12.4.5.1.4 China Molecular Diagnostics Market by Application 12.4.5.1.5 China Molecular Diagnostics Market by End Users 12.4.5.2 India 12.4.5.2.1 India Molecular Diagnostics Market by Product 12.4.5.2.2 India Molecular Diagnostics Market by Technique 12.4.5.2.3 India Molecular Diagnostics Market by Application 12.4.5.2.4 India Molecular Diagnostics Market by End Users 12.4.5.3 Japan 12.4.5.3.1 Japan Molecular Diagnostics Market by Product 12.4.5.3.2 Japan Molecular Diagnostics Market by Technique 12.4.5.3.3 Japan Molecular Diagnostics Market by Application 12.4.5.3.4 Japan Molecular Diagnostics Market by End Users 12.4.5.4 Australia 12.4.5.4.1 Australia Molecular Diagnostics Market by Product 12.4.5.4.2 Australia Molecular Diagnostics Market by Technique 12.4.5.4.3 Australia Molecular Diagnostics Market by Application 12.4.5.4.4 Australia Molecular Diagnostics Market by End Users 12.4.5.5 Rest of APAC Market Insight 12.4.5.5.1 Rest of APAC Molecular Diagnostics Market by Product 12.4.5.5.2 Rest of APAC Molecular Diagnostics Market by Technique 12.4.5.5.3 Rest of APAC Molecular Diagnostics Market by Application 12.4.5.5.4 Rest of APAC Molecular Diagnostics Market by End Users 12.5 Rest of World Market Insight 12.5.1 Rest of World Molecular Diagnostics Market by Product 12.5.2 Rest of World Molecular Diagnostics Market by Technique 12.5.3 Rest of World Molecular Diagnostics Market by Application 12.5.4 Rest of World Molecular Diagnostics Market by End Users 12.5.5 Rest of World Molecular Diagnostics Market by Country 12.5.5.1 Brazil 12.5.5.1.1 Brazil Molecular Diagnostics Market by Product 12.5.5.1.2 Brazil Molecular Diagnostics Market by Technique 12.5.5.1.3 Brazil Molecular Diagnostics Market by Application 12.5.5.1.4 Brazil Molecular Diagnostics Market by End Users 12.5.5.2 Other Rest of World 12.5.5.2.1 Other Rest of World Molecular Diagnostics Market by Product 12.5.5.2.2 Other Rest of World Molecular Diagnostics Market by Technique 12.5.5.2.3 Other Rest of World Molecular Diagnostics Market by Application 12.5.5.2.4 Other Rest of World Molecular Diagnostics Market by End Users 13 COMPETITIVE SCENARIO 13.1 Porter’s Five forces analysis 13.1.1 Bargaining Power of Suppliers 13.1.2 Bargaining Power of Buyers 13.1.3 Threat of New Entrants 13.1.4 Threat of Substitutes 13.1.5 Industry Rivalry 13.2 Market Share Analysis, by Company 13.2.1 Molecular Diagnostics Market Share Analysis by Company 2018 14 TOP COMPANY PROFILES 14.1 Abbott Laboratories 14.1.1 Key Facts 14.1.2 Business Description 14.1.3 Key Product/Services Offerings 14.1.4 Growth Strategy 14.1.5 SWOT Analysis 14.1.6 Key Financials 14.1.6.1 Revenue Split 14.1.7 Recent Developments 14.1.7.1 Product Launches 14.1.7.2 Partnership 14.1.7.3 Merger and Acquisition 14.2 Becton, Dickinson and Company 14.2.1 Key Facts 14.2.2 Business Description 14.2.3 Key Product/Services Offerings (AI Technology) 14.2.4 Growth Strategy 14.2.5 SWOT Analysis 14.2.6 Key Financials 14.2.6.1 Revenue Split 14.2.7 Recent Developments 14.2.7.1 Product Launches 14.2.7.2 Business Expansions and Investments 14.2.7.3 Merger & Acquisitions 14.3 Biomérieux SA 14.3.1 Key Facts 14.3.2 Business Description 14.3.3 Key Product/Services Offerings 14.3.4 Growth Strategy 14.3.5 SWOT Analysis 14.3.6 Key Financials 14.3.6.1 Revenue Split 14.3.7 Recent Developments 14.3.7.1 Product Launches 14.3.7.2 Partnerships 14.3.7.3 Mergers and Acquisitions 14.4 Hologic, Inc. 14.4.1 Key Facts 14.4.2 Business Description 14.4.3 Key Product/Services Offerings 14.4.4 Growth Strategy 14.4.5 SWOT Analysis 14.4.6 Key Financials 14.4.6.1 Revenue Split 14.4.7 Recent Developments 14.4.7.1 Product Launches 14.4.7.2 Partnerships 14.4.7.3 Business Expansion & Investment 14.4.7.4 Mergers and Acquisitions 14.5 Danaher Corporation 14.5.1 Key Facts 14.5.2 Business Description 14.5.3 Key Product/Services Offerings 14.5.4 Growth Strategy 14.5.5 SWOT Analysis 14.5.6 Key Financials 14.5.6.1 Revenue Split 14.5.7 Recent Developments 14.5.7.1 Merger and Acquisitions 14.6 Qiagen 14.6.1 Key Facts 14.6.2 Business Description 14.6.3 Key Product/Services Offerings 14.6.4 Growth Strategy 14.6.5 Key Milestones 14.6.6 SWOT Analysis 14.6.7 Key Financials 14.6.7.1 Revenue Split 14.6.8 Recent Developments 14.6.8.1 Product Launches 14.6.8.2 Partnerships 14.6.8.3 Business Expansions and Investment 14.6.8.4 Mergers and Acquisitions 14.7 Roche Holding AG 14.7.1 Key Facts 14.7.2 Business Description 14.7.3 Key Product/Services Offerings 14.7.4 Growth Strategy 14.7.5 SWOT Analysis 14.7.6 Key Financials 14.7.6.1 Revenue Split 14.7.7 Recent Developments 14.7.7.1 Product Launches 14.7.7.2 Partnership 14.7.7.3 Mergers and Acquisitions 14.8 Siemens Healthineers AG 14.8.1 Key Facts 14.8.2 Business Description 14.8.3 Key Product/Services Offerings 14.8.4 Growth Strategy 14.8.5 SWOT Analysis 14.8.6 Key Financials 14.8.6.1 Revenue Split 14.8.7 Recent Developments 14.8.7.1 Product Launches 14.8.7.2 Partnership 14.8.7.3 Business Expansion and Investment 14.8.7.4 Merger and Acquisitions 14.9 Thermo Fisher Scientific 14.9.1 Key Facts 14.9.2 Business Description 14.9.3 Key Product/Services Offerings 14.9.4 Growth Strategy 14.9.5 SWOT Analysis 14.9.6 Key Financials 14.9.6.1 Revenue Split 14.9.7 Recent Developments 14.9.7.1 Product Launch 14.9.7.2 Partnerships 14.9.7.3 Expansion and Investment 14.9.7.4 Merger and Acquisition 14.1 Sysmex Corporation 14.10.1 Key Facts 14.10.2 Business Description 14.10.3 Key Product/Services Offerings 14.10.4 Growth Strategy 14.10.5 SWOT Analysis 14.10.6 Key Financials 14.10.6.1 Revenue Split 14.10.7 Recent Developments 14.10.7.1 Product Launches 14.10.7.2 Partnership 14.10.7.3 Business Expansion & Investments 14.10.7.4 Merger and Acquisitions

Analyzing historical market, estimation of the current market and forecasting the future market for Global Molecular Diagnostics were the three major steps undertaken to create and analyze the overall adoption rate of Molecular Diagnostics services in major regions/countries globally. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the Molecular Diagnostics. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of Molecular Diagnostics market at Global scale. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the current and forecast market size of segments and sub-segments of the technology. Detailed methodology is explained below: Analysis of Historical Market Size Step 1: In-Depth Study of Secondary Sources: Detail secondary study was conducted to obtain the historical market size of the Global Molecular Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used. Step 2: Market Segmentation: After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global Molecular Diagnostics. Major segments included in the report are product type, technique, application and end-users. Further detailed regional/country-level analysis was also conducted to analyze the overall penetration rate of the technology Step 3: Factor Analysis: After acquiring the historical market size of different segments and sub-segments detailed factor analysis was conducted to estimate the current market size of the Global Molecular Diagnostics. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global Molecular Diagnostics and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied. Current Market Size Estimate & Forecast Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews. Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, trends and opportunities available in the market. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments for major regions/countries. The research methodology adopted to estimate the market size encompasses: The industry’s market size, in terms of value and rate of adoption of Molecular Diagnostics technique g lobally

All percentage shares, splits, and breakdowns of market segments and sub-segments

Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global Molecular Diagnostics market Market Size and Share Validation Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarized, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights. Split of Primary Participants Market Engineering Data triangulation technique was employed to complete the overall market engineering process and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the Global Molecular Diagnostics market. Data was split into several segments post studying various parameters and trends in the areas of product type, technique such as Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization & FISH, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and applications and regions such as North America, Europe, APAC among others Main objective of the Global Molecular Diagnostics Market Study The current & future market trends of the global Molecular Diagnostics market are pinpointed in the study. The investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. The current and future market trends would determine the overall attractiveness of the market, providing a platform for the diagnostics healthcare participant to exploit the untapped market to benefit as the first-mover advantage. Other quantitative goals of the studies include: Analyze the current and forecast market size of the global Molecular Diagnostics market in terms of value (US$) and volume

Analyze the current and forecast market size of different segments and sub-segments of the global Molecular Diagnostics market

To analyze the revenue and business models of the market players in the industry

To understand the initiatives undertaken by diagnostics companies Vs service providers to increase the overall analysis of Molecular Diagnostics in major regions

Define and describe the segments and sub-segments considered in the evaluation of the global Molecular Diagnostics market and anticipate potential risk associated with the market

Define and analysis of the government regulations for diagnostics

Analyze the current and forecast market size of the global Molecular Diagnostics market for major regions/countries including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World) Define and analyze the competitive landscape of the global Molecular Diagnostics market and the growth strategies adopted by the market players to sustain in the fast-growing market

Analyzing historical market, estimation of the current market and forecasting the future market for Global Molecular Diagnostics were the three major steps undertaken to create and analyze the overall adoption rate of Molecular Diagnostics services in major regions/countries globally. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the Molecular Diagnostics. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of Molecular Diagnostics market at Global scale. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the current and forecast market size of segments and sub-segments of the technology. Detailed methodology is explained below: Analysis of Historical Market Size Step 1: In-Depth Study of Secondary Sources: Detail secondary study was conducted to obtain the historical market size of the Global Molecular Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used. Step 2: Market Segmentation: After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global Molecular Diagnostics. Major segments included in the report are product type, technique, application and end-users. Further detailed regional/country-level analysis was also conducted to analyze the overall penetration rate of the technology Step 3: Factor Analysis: After acquiring the historical market size of different segments and sub-segments detailed factor analysis was conducted to estimate the current market size of the Global Molecular Diagnostics. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global Molecular Diagnostics and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied. Current Market Size Estimate & Forecast Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews. Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, trends and opportunities available in the market. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments for major regions/countries. The research methodology adopted to estimate the market size encompasses: The industry’s market size, in terms of value and rate of adoption of Molecular Diagnostics technique g lobally

All percentage shares, splits, and breakdowns of market segments and sub-segments

Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global Molecular Diagnostics market Market Size and Share Validation Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarized, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights. Split of Primary Participants Market Engineering Data triangulation technique was employed to complete the overall market engineering process and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the Global Molecular Diagnostics market. Data was split into several segments post studying various parameters and trends in the areas of product type, technique such as Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization & FISH, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and applications and regions such as North America, Europe, APAC among others Main objective of the Global Molecular Diagnostics Market Study The current & future market trends of the global Molecular Diagnostics market are pinpointed in the study. The investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. The current and future market trends would determine the overall attractiveness of the market, providing a platform for the diagnostics healthcare participant to exploit the untapped market to benefit as the first-mover advantage. Other quantitative goals of the studies include: Analyze the current and forecast market size of the global Molecular Diagnostics market in terms of value (US$) and volume

Analyze the current and forecast market size of different segments and sub-segments of the global Molecular Diagnostics market

To analyze the revenue and business models of the market players in the industry

To understand the initiatives undertaken by diagnostics companies Vs service providers to increase the overall analysis of Molecular Diagnostics in major regions

Define and describe the segments and sub-segments considered in the evaluation of the global Molecular Diagnostics market and anticipate potential risk associated with the market

Define and analysis of the government regulations for diagnostics

Analyze the current and forecast market size of the global Molecular Diagnostics market for major regions/countries including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World) Define and analyze the competitive landscape of the global Molecular Diagnostics market and the growth strategies adopted by the market players to sustain in the fast-growing market